Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P51530: Variant p.Val637Ile

DNA replication ATP-dependent helicase/nuclease DNA2
Gene: DNA2
Feedback?
Variant information Variant position: help 637 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Valine (V) to Isoleucine (I) at position 637 (V637I, p.Val637Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PEOA6; the mutant protein has decreased nuclease activity (30% of wild-type) and enhanced helicase activity; consistent with a loss of function mutation. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 637 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1060 The length of the canonical sequence.
Location on the sequence: help DTVACILKGLNKPQRQAMKK V LLSKDYTLIVGMPGTGKTTT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DTVACILKGLNKPQRQAMKKVLLSKDYTLIVGMPGTGKTTT

Mouse                         DTVANILKGLNKPQRQAMKRVLLSKDYTLIVGMPGTGKTTT

Rat                           DTVANILKGLNKPQRQAMKKVLLSKDYTLIVGMPGTGKTTT

Bovine                        DTVACILKGLNKPQRQAMKKVLLSKDYTLIVGMPGTGKTTT

Chicken                       EAVASILKGLNKPQKQAMKQVLLSRDYTLIVGMPGTGKTTT

Xenopus laevis                DIVASILRGLNKPQKQAMKRVLLSKDYTLIVGMPGTGKTTT

Xenopus tropicalis            DIVANILKGLNKPQKQAMKRVLLSKDYTLIVGMPGTGKTTT

Baker's yeast                 DTT------LNLNQKEAIDKVMRAEDYALILGMPGTGKTTV

Fission yeast                 -----FLKCLNEDQITALKKCHAAEHYSLILGMPGTGKTTT
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1060 DNA replication ATP-dependent helicase/nuclease DNA2
Region 520 – 1060 Helicase activity
Mutagenesis 654 – 654 K -> E. Abolishes ability to unwind DNA, while it does not affect ability to resect DNA.



Literature citations
Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability.
Ronchi D.; Di Fonzo A.; Lin W.; Bordoni A.; Liu C.; Fassone E.; Pagliarani S.; Rizzuti M.; Zheng L.; Filosto M.; Ferro M.T.; Ranieri M.; Magri F.; Peverelli L.; Li H.; Yuan Y.C.; Corti S.; Sciacco M.; Moggio M.; Bresolin N.; Shen B.; Comi G.P.;
Am. J. Hum. Genet. 92:293-300(2013)
Cited for: VARIANTS PEOA6 HIS-198; GLU-227 AND ILE-637; CHARACTERIZATION OF VARIANTS PEOA6 HHIS-198; GLU-227 AND ILE-637;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.